Particular GmbH, a new German nanotechnology company, is the first company to commercialize a novel process for the production of highly pure nanoparticles. The developments werde made at Laser Zentrum Hannover e. V. (LZH) and took five years. Niko Bärsch, CEO of Particular, explains that their nanoparticles make it easier to take advantage of nanotechnology for many products, especially in the field of medical technology. Nanoparticles are invisibly small material crumbs that improve products regarding features like biological compatibility, bacteria resistance, UV light absorption, or scratch resistance. While they are usually generated chemically, the new company produces them physically by laser ablation in liquids. This enables new kinds of nanoparticles, for example for metallic surfaces with securely attached nanostructures that make implants more compatible, or for a conjugation of smallest gold particles and biomolecules for biomedical applications such as cell separations. The website http://particular.eu/ provides an insight into the technology and the products of the company.
Latest from Today's Medical Developments
- Boston Scientific to acquire Penumbra, expanding cardiovascular portfolio
- Star Cutter introduces Double Pilot Reamer
- #80 Manufacturing Matters - Machining Strategies to Save Time and Improve your Process for MedTech Components with Kennametal Inc.
- Real-world parts and expert manufacturing advice
- Experts discuss the latest in toolholding technology
- How permanent magnets are powering medical innovation
- Forecasting the year ahead in design and manufacturing
- Tecomet, Orchid Orthopedic Solutions announce merger agreement